---
schema_version: "secwatch.filing_event.v1"
accession: "0001510964-22-000023"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2022-04-01T23:59:59+00:00"
generated_at: "2026-06-26T10:35:25.953174+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CV Sciences raises $700K via convertible preferred and warrants; seeks reverse split up to 1:400

## Summary
- Issued 700 shares of convertible preferred ($1,000 stated value) convertible into 10M shares at $0.07/sh, plus warrants for 10M shares at $0.10/sh.
- Gross proceeds $700K; placement agent fees 7.5% plus 1.0% management fee and warrants for 750K shares at $0.0875.
- To seek shareholder approval to increase authorized common from 190M to 790M and reverse stock split between 1:10 and 1:400.
- Preferred stock has 170,000 votes per share only on the proposals; no other voting rights; dividends on as-converted basis.
- Closing occurred March 31, 2022; warrants exercisable after shareholder approval, expire 3 years later; anti-dilution and reset provisions.

## SEC filing metadata
- accession: 0001510964-22-000023
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2022-04-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000151096422000023/0001510964-22-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000151096422000023/cvsi-20220330.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001510964-22-000023
- JSON: https://secwatch.observer/filing/0001510964-22-000023.json
- Plain text: https://secwatch.observer/filing/0001510964-22-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.